statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $50.74, but opened at $52.12. Praxis Precision...

Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Up to $50.74

Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) traded down 6.1% on Wednesday . The company traded as low as $51.82 and last traded at $52.18. 81,782 shares changed hands...

Praxis Precision Medicines (NASDAQ:PRAX) Stock Price Down 6.1%

BOSTON, April 05, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...

Praxis Precision Medicines to Participate in Upcoming April Conferences

BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Over the last three days, A.I.dvisor has detected that PRAX's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Praxis Precision Medicines (PRAX, $58.59) Aroon Indicator entered an Uptrend on April 01, 2024.

Praxis Precision Medicines, Inc. (NASDAQ:PRAX  Get Free Report) fell 3.8% during trading on Wednesday . The stock traded as low as $58.40 and last traded at $59.79. 51,993 shares were traded...

Praxis Precision Medicines (NASDAQ:PRAX) Trading Down 3.8%

Praxis Precision Medicines (PRAX, $60.92) Aroon Indicator entered an Uptrend on March 28, 2024.

Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX Research Report), GlycoMimetics...

Analysts' Top Healthcare Picks: Praxis Precision Medicines (PRAX), GlycoMimetics (GLYC)

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...

Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Praxis Precision Medicines announces offering of common stock, warrants

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. It is a targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Volume	75,998.00
52-Wk High	$67.21
52-Wk Low	$12.45

PRAX Praxis Precision Medicines Inc

About

Feed

News

Sentiment

Earnings

Fundamentals